Jonathan R. Goodman serves as Executive at POINT Biopharma Global Inc., where they oversee executive responsibilities. Since joining the company, Jonathan R. Goodman has executed 5 insider transactions totaling $38.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 26, 2023 involved transacting 41,872 shares valued at $0.
Jonathan R. Goodman currently holds 41,872 shares of POINT Biopharma Global Inc. (PNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan R. Goodman has been a net buyer of PNT stock. They have purchased $38.0K and sold $0 worth of shares.
Jonathan R. Goodman's most recent insider trade was on Dec 26, 2023, when they sold 41,872 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.33 |
| Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 35,872 | $N/A | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 35,872 | $N/A | Discretionary |
| Jun 30, 2021 | PNT | $0 | Award | 21,523 | $N/A | Discretionary |